Acute inhibition of hepatic beta-oxidation in APOE*3Leiden mice does not affect hepatic VLDL secretion or insulin sensitivity.
about
Genome-wide mRNA expression analysis of hepatic adaptation to high-fat diets reveals switch from an inflammatory to steatotic transcriptional program.Selective reversible inhibition of liver carnitine palmitoyl-transferase 1 by teglicar reduces gluconeogenesis and improves glucose homeostasis.Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.Dissociating fatty liver and diabetesFenofibrate increases very low density lipoprotein triglyceride production despite reducing plasma triglyceride levels in APOE*3-Leiden.CETP mice.Inhibition of mitochondrial fatty acid oxidation in vivo only slightly suppresses gluconeogenesis but enhances clearance of glucose in mice.
P2860
Acute inhibition of hepatic beta-oxidation in APOE*3Leiden mice does not affect hepatic VLDL secretion or insulin sensitivity.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Acute inhibition of hepatic be ...... retion or insulin sensitivity.
@en
Acute inhibition of hepatic be ...... retion or insulin sensitivity.
@nl
type
label
Acute inhibition of hepatic be ...... retion or insulin sensitivity.
@en
Acute inhibition of hepatic be ...... retion or insulin sensitivity.
@nl
prefLabel
Acute inhibition of hepatic be ...... retion or insulin sensitivity.
@en
Acute inhibition of hepatic be ...... retion or insulin sensitivity.
@nl
P2093
P2860
P1476
Acute inhibition of hepatic be ...... retion or insulin sensitivity.
@en
P2093
Folkert Kuipers
Ilse Duivenvoorden
Johannes A Romijn
Patrick C N Rensen
Peter J Voshol
P2860
P304
P356
10.1194/JLR.M400505-JLR200
P577
2005-02-16T00:00:00Z